They have the 20 patents for Paclitaxol (US and International). There certainly is an opportunity there, but there's a lot of competition in that market and it's been a long time since anything was done with it. They also do have the XetaPharm nutraceuticals, which could be brought back (and we'd like to do that if we take over).